The cost-effectiveness of nanotechnology depends on several factors including the initial investment in research and development (R&D), the scalability of production, and the economic value of the applications. While the initial R&D costs can be high, the long-term benefits often outweigh these expenses. For example, nanoscale drug delivery systems can reduce the overall cost of treatment by targeting diseased cells more effectively, thereby reducing the dosage required and minimizing side effects.
